VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EHAB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
EHABEnhabit, Inc.
$13.80$707M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksEHABCash Flow

Enhabit, Inc. (EHAB) Cash Flow Statement

6Y historyFree accessUpdated daily

Free cash flow remains inconsistent, with margins ranging from a negative 1.8% in 2024Q4 to a peak of 13.7% in 2025Q3, reflecting erratic cash conversion cycles.

EHAB Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20
Cash from Operations88M70.7M51.2M48.4M80.1M123.3M24.9M
Operating CF Margin %-6.67%4.95%4.63%7.48%11.14%2.31%
Operating CF Growth %347.48%38.09%5.79%-39.58%-35.04%395.18%-
Net Income-3.2M-2.6M-154M-80.5M-38.3M112.9M75M
Depreciation & Amortization20.8M22.5M31.5M30.9M33M36.9M40M
Stock-Based Compensation16.5M16.6M11.7M8.9M9.2M3.6M0
Deferred Taxes500K0-5.7M-11.6M-4.3M8.6M18.5M
Other Non-Cash Items51.7M30.4M162.6M89M109.7M-5.9M3.5M
Working Capital Changes-400K3.8M5.1M11.7M-29.2M-32.8M-112.1M
Change in Receivables6.5M5.2M15.5M-14.6M21.6M-24.8M-32.9M
Change in Inventory0000000
Change in Payables600K2.6M-1M3.8M200K-700K-500K
Cash from Investing-6.7M16.7M-2.4M-5.3M-42.3M-119.2M-3M
Capital Expenditures-7.1M-4.9M-3.8M-3.5M-7.1M-4.3M-3.6M
CapEx % of Revenue0.67%0.46%0.37%0.33%0.66%0.39%0.33%
Acquisitions000-2.8M-36.3M-117.5M-1.1M
Investments-------
Other Investing300K19.8M1.4M1M1.1M2.6M1.7M
Cash from Financing-70.6M-72.2M-48.3M-40.5M-18.6M-36.1M-16.7M
Debt Issued (Net)-64.5M-67.7M-43.6M-33.4M575M-7.2M5.1M
Equity Issued (Net)000000124M
Dividends Paid0000-654.9M-154.1M-144.5M
Share Repurchases0000000
Other Financing-6.1M-4.5M-4.7M-7.1M61.3M125.2M-1.3M
Net Change in Cash10.7M15.2M500K2.6M19.2M-32M40M
Free Cash Flow80.9M65.8M47.4M44.9M73M119M21.7M
FCF Margin %7.6%6.21%4.58%4.29%6.82%10.75%2.01%
FCF Growth %63.43%38.82%5.57%-38.49%-38.66%448.39%-
FCF per Share1.531.300.940.901.4630.515.56
FCF Conversion (FCF/Net Income)-25.28x-15.37x-0.33x-0.60x-1.98x1.11x0.33x
Interest Paid7.9M00013.1M200K0
Taxes Paid000011.9M28.4M0

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Medicare Advantage reimbursement compression

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Masked by Volatility

According to quarterly cash flow statements, the relationship between net income and operating cash flow is highly erratic, with OCF/NI ratios swinging from 86.50 in 2024Q1 to -0.11 in 2025Q4, suggesting that reported net income is a poor proxy for the company's actual cash-generating capacity.

The extreme divergence between accounting profits and cash flow indicates that non-cash charges and working capital fluctuations are heavily distorting the bottom line. Investors should monitor whether this instability reflects genuine operational friction or merely the accounting noise inherent in the company's post-spin-off transition.

Free Cash Flow Margin Instability

As reported in financial filings, Enhabit's free cash flow margins have demonstrated significant inconsistency, ranging from a negative 1.8% in 2024Q4 to a peak of 13.7% in 2025Q3, highlighting the difficulty in maintaining a predictable cash conversion cycle amidst ongoing operational and reimbursement headwinds.

The lack of a stable FCF trajectory suggests that the company's cash generation is highly sensitive to episodic revenue timing and labor-related cost spikes. This volatility warrants further investigation into whether the business can achieve sustainable cash flow growth without relying on favorable working capital swings.

Minimal Capital Intensity Sustains Liquidity

Based on recent SEC filings, Enhabit maintains a remarkably low capital intensity, with CapEx/Revenue ratios consistently remaining below 1% over the last ten quarters, which effectively preserves cash flow for operational needs despite the company's broader challenges in achieving consistent profitability and margin expansion.

The low level of capital expenditure suggests that the business model is not asset-heavy, which provides a degree of protection against liquidity crunches. However, investors should consider whether this minimal investment level is sufficient to maintain the clinical quality and technology infrastructure required to compete for Medicare Advantage contracts.

Working Capital Swings Drive Liquidity

As evidenced by the quarterly data, working capital changes have been a primary driver of cash flow volatility, with shifts ranging from a $17.9 million inflow in 2025Q3 to a $14.9 million outflow in 2025Q4, indicating that cash availability is heavily dependent on collection cycles.

The reliance on working capital fluctuations to bolster operating cash flow suggests that the company's underlying cash generation is less robust than headline figures might imply. This pattern may indicate challenges in managing accounts receivable, particularly as the payer mix shifts toward more complex Medicare Advantage plans.

EHAB — Frequently Asked Questions

Quick answers to the most common questions about buying EHAB stock.

How much cash does Enhabit, Inc. (EHAB) generate from operations?

Enhabit, Inc. (EHAB) generated $70.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Enhabit, Inc.'s free cash flow?

Enhabit, Inc. (EHAB) generated $65.8M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Enhabit, Inc.'s capital expenditure (CapEx)?

Enhabit, Inc. (EHAB) spent $4.9M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.